Laura Fanucchi

Primary care, addiction medicine physician and researcher.

[Paul Christine @pauljchristine]

We have new work out today @JAMAHealthForum exploring if removal of Medicaid prior auths for buprenorphine changed buprenorphine prescriptions

Hypothesis: PAs are a barrier to care and removal will result in more prescriptions

Results: There was minimal change after PA removal

[Anna-Maria South, MD, FACP, FASAM @AnnaMariaSouth]

Initiation of MOUD may improve readmissions in patient directed discharges @Dr_Robertson_MD @LauraFanucchi

[Laura Fanucchi @LauraFanucchi]

Kudos @Dr_Robertson_MD 📢 initiating MOUD in the hospital for people with OUD is critical to improve outcomes @UKYMedicine

[Nicole Robertson MD, MPH @Dr_Robertson_MD]

Patient-directed discharge carries higher 30-day readmission rate compared to standard discharge. Strategies to reduce PDD rates and increase MOUD initiation may improve readmission outcomes. Thank you @IDSA G.E.R.M. for funding our study @JSATjournal
https://t.co/AxOWxGooYu

[UK Hospitalists @UKHospitalists]

🌟🌟Amazing work @AnnaMariaSouth @LauraFanucchi Lofwall🌟🌟

We are proud of your continued commitment and support for the incarcerated population with Opioid Use Disorder. #UK_HealthCare @UKYMedicine @DarwinConwell @alicecthornton #advocacy #compassion
https://t.co/HHluvBfVQi

[Daniel Weaver @dtweaverMD]

Congratulations to my nontweeting colleague Dr South, Dr. Lofwall and ⁦@LauraFanucchi⁩ Treating Opioid Use Disorder in Patients Who Are Incarcerated: Quandaries of a Hospitalist | Substance Use and Addiction Medicine | JAMA | JAMA Network https://t.co/N0xtxpvxR9

[Daniel Weaver @dtweaverMD]

via @NYTimes I hope it is available over OTC soon. https://t.co/MvxHFTTZh7

[Journal of Substance Use & Addiction Tx (JSAT) @JSATjournal]

We are delighted to announce that JSAT’s underlying name has been officially changed to Journal of Substance Use & Addiction Treatment. Thanks to all who supported this change. #wordsmatter #stigmakills

https://t.co/wRmauczg69

[KHA1 Lexington G06/07 @KHB_07G]

Catch us in action this weekend at the @NationalLeague Orlando E64 Showcase! Good luck to all clubs competing, especially our fellow @kingshammer teams. #EarnYourPlace 💪🏼⚽️

[Laura Fanucchi @LauraFanucchi]

@AMERSA_tweets

[Laura Fanucchi @LauraFanucchi]

Here at #AMERSA2022 and just saw this incredible news from my home state - https://t.co/nQVlvJWypx

[Laura Fanucchi @LauraFanucchi]

@DrEllenEaton Thanks @elleneaton @dsolsMD and team!

[Ellen Eaton @DrEllenEaton]

Fantastic work led by ⁦⁦@dsolsMD⁩ on OPAT eligibility 4 PWID. Clinicians who report PWID = not eligible for OPAT are more likely to cite (unfounded) picc safety, legal risks. They also report less social, case mgmt support. Great collab, 🤩 team! ⁦@IDWeek2022⁩

[Ellen Eaton @DrEllenEaton]

🚨 Imp Guidance on Injection-related Endocarditis. Especially helpful 4 #IDtwitter, clinicians, pharmacists who are working 2 develop evidence-based protocols. Highlights role of stigma, oral & LA antibiotics, & bup/methadone 👏🏻 👏🏻 @IDDoc1978 @LauraFanucchi

[LBaddour @LBaddour1]

Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association https://t.co/Tn6p20VAgo

@MayoClinicGIM @MayoMN_IMRES @MayoPsych @IDSAInfo @ACCinTouch @ACPinternists @escardio @JWatch @STS_CTsurgery @ESCMID @ACEPNow 🧵

[Laura Fanucchi @LauraFanucchi]

Yes! Thank you @honoraenglander @coreysdavis for this powerful call to action. Proud that @universityofky @UK_HealthCare we have addiction consult & @UKHospitalists all getting waivered! @dtweaverMD @DevinOller @romilchadha @PeterAkpunonu

[Adi @IDdocAdi]

Trying to get funding for research

[LBaddour @LBaddour1]

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomi… https://t.co/nU5zf13hsh

🎯🎯🎯 Thank you for the heavy lifting Laura and colleagues. @MayoClinicINFD

[Therapeutic Advances in Infectious Disease @TAInfDis]

📣NEW online! Design & protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a RCT of integrated outpatient treatment of opioid use disorder & severe, injection-related infections @LauraFanucchi @universityofky ⬇
https://t.co/50rifLePdK

[David Hogg 🟧 @davidhogg111]

I’m telling you this time is going to be different

[Amanda Gorman @TheAmandaGorman]

Schools scared to death.
The truth is, one education under desks,
Stooped low from bullets;
That plunge when we ask
Where our children
Shall live
& how
& if